中国学者近期发表的论文
1.	Molecular classification of IDH-mutant glioblastomas based on gene expression profiles. Author: Wu F1,2,3, Chai RC1,2,3, Wang Z1,2,3, Liu YQ1,2,3, Zhao Z1,2,3, Li GZ1,2,3, Jiang HY1,2,3. Journal: Carcinogenesis. 2019 Feb 13. pii: bgz032. doi: 10.1093/carcin/bgz032. [Epub ahead of print]    PubMed      DOI
2.	Oxytocin involves in chronic stress-evoked melanoma metastasis via β-arrestin 2-mediated ERK signaling pathway. Author: Ji H1, Liu N2, Li J3, Chen D4, Luo D5, Sun Q5, Yin Y3, Liu Y6, Bu B7, Chen X1, Li J5. Journal: Carcinogenesis. 2019 Mar 22. pii: bgz064. doi: 10.1093/carcin/bgz064. [Epub ahead of print]    PubMed      DOI
3.	Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer. Author: Mo S1,2, Dai W1,2, Xiang W1,2, Li Y1,2, Feng Y1,2, Zhang L1,3, Li Q1,2, Cai G1,2. Journal: Carcinogenesis. 2019 Feb 19. pii: bgz031. doi: 10.1093/carcin/bgz031. [Epub ahead of print]    PubMed      DOI
4.	A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations. Author: Chang JW1,2, Ding Y1,2, Tahir Ul Qamar M1,2, Shen Y1, Gao J1, Chen LL1,2. Journal: Carcinogenesis. 2019 Apr 4. pii: bgz044. doi: 10.1093/carcin/bgz044. [Epub ahead of print]    PubMed      DOI
5.	ARHGAP4 regulates the cell migration and invasion of pancreatic cancer by the HDAC2/β-catenin signaling pathway. Author: Shen Y1,2, Xu L1,2, Ning Z1,2, Liu L1,2, Lin J1,2, Chen H1,2, Meng Z1,2. Journal: Carcinogenesis. 2019 Apr 8. pii: bgz067. doi: 10.1093/carcin/bgz067. [Epub ahead of print]    PubMed      DOI
6.	Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. Author: Luo D1,2,3, Fraga-Lauhirat M1, Millings J4, Ho C1, Villarreal EM1, Fletchinger TC1, Bonfiglio JV4, Mata L4, Nemesure MD4, Bartels LE4, Wang R4, Rigas B5,6, Mackenzie GG1,4. Journal: Carcinogenesis. 2019 Apr 17. pii: bgz069. doi: 10.1093/carcin/bgz069. [Epub ahead of print]    PubMed      DOI
7.	circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Author: Zou Y1, Zheng S1, Xiao W1, Xie X1, Yang A1, Gao G1, Xiong Z1, Xue Z1, Tang H1, Xie X1. Journal: Carcinogenesis. 2019 Apr 17. pii: bgz071. doi: 10.1093/carcin/bgz071. [Epub ahead of print]    PubMed      DOI
8.	Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study. Author: Wang Q1,2, Tu H2, Zhu M2,3, Liang D4, Ye Y2,5, Chang DW2, Long Y2,6, Wu X2,5. Journal: Carcinogenesis. 2019 Apr 17. pii: bgz074. doi: 10.1093/carcin/bgz074. [Epub ahead of print]    PubMed      DOI
9.	SMYD3 promotes epithelial ovarian cancer metastasis by down-regulating p53 protein stability and promoting p53 ubiquitination. Author: Zhang L1, Jin Y1, Yang H2, Li Y1, Wang C1, Shi Y3, Wang Y1. Journal: Carcinogenesis. 2019 Apr 19. pii: bgz078. doi: 10.1093/carcin/bgz078. [Epub ahead of print]    PubMed      DOI
10.	The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization. Author: Tang DE1, Dai Y1, Xu Y1, Liu DZ1, Hong XP1, Ou ML1, Jiang HW2, Xu SH1,3. Journal: Carcinogenesis. 2019 May 2. pii: bgz085. doi: 10.1093/carcin/bgz085. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 160.19 Nature Reviews Clinical Oncology 127 8.04 NATURE REVIEWS CANCER 396 23.23 LANCET ONCOLOGY 274 10.07 JOURNAL OF CLINICAL ONCOLOGY 494 11.08 CANCER CELL 295 15.04 ANNALS OF ONCOLOGY 210 8.44 SEMINARS IN CANCER BIOLOGY 134 8.86 CLINICAL CANCER RESEARCH 292 8.32 CANCER RESEARCH 411 6.94

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 286010 CANCER RESEARCH 163641 International Journal of Nanomedicine 162051 Molecular Medicine Reports 161919 CANCER LETTERS 157138 JOURNAL OF ETHNOPHARMACOLOGY 138968 BIOMEDICINE & PHARMACOTHERAPY 136941 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133578 Theranostics 132882 International Journal of Environmental Research and Public Health 131239